VISDB Viral Integration Site DataBase

VIS ID

TVIS30014930

Fusion event

HIV-LIMA1 integration

Validated

Yes

Detection method

LM PCR

Data source

Curated

Sample type

Disease

HIV-infected disease (HID)

Quality evaluation

Good

Reported year

2014

PubMed ID

Virus name

HIV

Reference genome

Not given

Chromosome

chr12

Cytoband

q13.12

Reference genome

Start

End

50581379/50187467 (Hg38)

Orient

+

Location type

Intronic

Fragile sites / regions

Target gene

miRNAs that regulate target gene

hsa-mir-130b-3p ; hsa-mir-93-5p ; hsa-mir-33a-5p ; hsa-mir-27a-3p ; hsa-mir-877-3p ; hsa-mir-339-5p ; hsa-mir-365a-3p ; hsa-mir-186-5p ; hsa-mir-10a-5p ; hsa-mir-30c-5p ; hsa-mir-16-5p ; hsa-mir-4775 ; hsa-mir-190a-3p ; hsa-mir-5011-5p ; hsa-mir-875-5p ; hsa-mir-20a-5p ; hsa-mir-106b-5p ; hsa-mir-499a-3p ; hsa-mir-670-3p ; hsa-mir-6891-3p ; hsa-mir-6072 ; hsa-mir-3074-3p ; hsa-mir-451b ; hsa-mir-3120-3p ; hsa-mir-3152-5p ; hsa-mir-6805-3p ; hsa-mir-5691 ; hsa-mir-6836-3p ; hsa-mir-3144-3p ; hsa-mir-4777-3p ; hsa-mir-3613-5p ; hsa-mir-496 ; hsa-mir-3194-3p ; hsa-mir-367-5p ; hsa-mir-1267 ; hsa-mir-616-5p ; hsa-mir-373-5p ; hsa-mir-371b-5p ; hsa-mir-3613-3p ; hsa-mir-520e ; hsa-mir-520d-3p ; hsa-mir-520c-3p ; hsa-mir-520b ; hsa-mir-520a-3p ; hsa-mir-373-3p ; hsa-mir-372-3p ; hsa-mir-302e ; hsa-mir-302d-3p ; hsa-mir-302c-3p ; hsa-mir-302b-3p ; hsa-mir-302a-3p ; hsa-mir-548t-5p ; hsa-mir-548az-5p ; hsa-mir-106a-5p ; hsa-mir-526b-3p ; hsa-mir-519d-3p ; hsa-mir-20b-5p ; hsa-mir-17-5p ; hsa-mir-5096 ; hsa-mir-29b-2-5p ; hsa-mir-6802-3p ; hsa-mir-299-5p ; hsa-mir-6814-5p ; hsa-mir-3620-3p ; hsa-mir-6865-3p ; hsa-mir-4259 ; hsa-mir-4715-5p ; hsa-mir-6768-3p ; hsa-mir-519c-3p ; hsa-mir-519b-3p ; hsa-mir-519a-3p ; hsa-mir-4796-3p ; hsa-mir-3609 ; hsa-mir-548ah-5p

Nearest miRNA

hsa-mir-1244-3/Upstream/1415430; hsa-let-7i/Downstream/46675;

Nearest TSS

Nearest CpG islands

None/Target, chr12-CpG: 104/Upstream/19864, chr12-CpG: 38/Downstream/96004

Nearest cancer related gene

LIMA1(TSG, No orient, 0)

Upstream sequence

AAATGCCTTTCATTCCTTCCAATTTGTGTAAAATATCTAGGTAATGAAACTGAAATTCTTCACCACACAGCAAATGGTTGGGCCAGCCCTGTGCAGCCTT

Downstream sequence

AAAAGATTCTAGACACTCTTCTAGCATAATTTTGACAGCTTTGCAAGCCAGCATAAAACCTCCCACTGTGTCTTCAGGGGGAGGAACAGCTGGCAGGGTA

Target sequence

AACCCTTCCTCTAATTTTCTGTGAAACTCTATGAAAGCATTTTGGGGAATATTCATATCTTAAATAGAGTGCTCTACACAGAGAAGAAAGGACAGTCCTCTGAAAAGGCAGTAATAGTGAGTGAGTGAG